Diana Balekian is a Rheumatology/Immunology physician affiliated with Massachusetts General Hospital. OpenAlex indexes 15 publications with 375 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
114r Highland Ave
Salem, MA 019702723
Telephone
978-745-3711Provider last certified this registry record 15 Dec 2021.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year20241 payment
- GlaxoSmithKline, LLC.Program year20231 payment
- AstraZeneca Pharmaceuticals LPProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
94.3%Corticosteroid45.2%Fluticasone Propionate33%Breo Ellipta20%Trelegy Ellipta13%Pulmicort Flexhaler8%Qvar Redihaler8%Budesonide-Formoterol Fumarate6%Symbicort5%Arnuity Ellipta5%Part D<11 patientsHistamine-1 Receptor Antagonist20.2%Azelastine Hcl87%Levocetirizine Dihydrochloride13%Part D<11 patients+ 4 more classes in this area
Dermatology
3.3%Interleukin-4 Receptor alpha Antagonist3.3%Dupixent Pen100%Part D<11 patientsMetabolism & gastrointestinal
2.4%H2 blocker2.4%Famotidine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Prenatal and postnatal tobacco smoke exposure and risk of severe bronchiolitis during infancy
Respiratory Medicine
2018 - Changes in emergency department concordance with guidelines for the management of stinging insect-induced anaphylaxis
Annals of Allergy Asthma & Immunology
2018 - Addressing Inpatient Beta-Lactam Allergies: A Multihospital Implementation
The Journal of Allergy and Clinical Immunology In Practice
2017 - Changes in Emergency Department Concordance with Guidelines for the Management of Food-Induced Anaphylaxis: 1999-2001 Versus 2013-2015
Journal of Allergy and Clinical Immunology
2017 - Changes in Emergency Department Concordance with Guidelines for the Management of Insect Sting-Induced Anaphylaxis: 1999-2001 Versus 2013-2015
Journal of Allergy and Clinical Immunology
2017
Similar KOLs
Other experts from the same institution or the same specialty.
James Januzzi, MD
Massachusetts General Hospital
Maurizio Fava, MD
Massachusetts General Hospital
Steven Greenberg, MD
Massachusetts General Hospital
David Scadden, MD
Massachusetts General Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”